The AHA Nov. 7 filed a friend-of-the-court brief in the U.S. District Court for the District of Kansas in defense of the state's law protecting against deceptive acts or practices related to 340B pricing for contract pharmacy arrangements.  
 
The AHA has filed similar briefs in multiple states, including most recently in Minnesota, Missouri and West Virginia.  
  
Comparable laws have been upheld in Louisiana and Maryland.  
  
Joining the AHA in the Nov. 7 filing were 340B Health, the Kansas Hospital Association, the Community Care Network of Kansas and the American Society of Health-system Pharmacists.

Related News Articles

Headline
The AHA, 340B Health, the Minnesota Hospital Association and American Society of Health-system Pharmacists Oct. 4 filed an amicus brief in the U.S. District…
Headline
A Louisiana district court Sept. 30 upheld a state law prohibiting drug companies from denying Louisiana hospitals 340B discounts for drugs dispensed at…
Headline
Johnson & Johnson Sept. 30 notified the Health Resources and Services Administration that it is ceasing implementation of its proposed 340B rebate model.…
Headline
The Health Resources and Services Administration Sept. 27 sent a final warning letter to Johnson & Johnson urging the company to inform the agency by…
Headline
“As pharmaceutical companies throw stone after stone at the 340B program, they should beware of their own glass house. Their complaints ring hollow when it is…
Headline
The Health Resources and Services Administration Sept. 17 told Johnson & Johnson that the company’s publicly announced plans to implement a 340B rebate…